Tumor mutation burden, along with anti-programmed death-ligand 1 (PD-L1) expression, has demonstrated utility as a biomarker for immune checkpoint ...
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2QGTNvr
Tumor mutation burden, along with anti-programmed death-ligand 1 (PD-L1) expression, has demonstrated utility as a biomarker for immune checkpoint ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.